| Stage | PFE | % of rev | CMI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $16.6B | 100.00% | $9.5B | 100.00% | PFE ×1.75 |
| Gross profit | $12.6B | 75.71% | $2.5B | 26.07% | PFE +49.6pp |
| Operating income | $3.7B | 22.14% | $1.3B | 13.52% | PFE +8.6pp |
| Pre-tax income | $3.4B | 20.41% | $1.3B | 13.67% | PFE +6.7pp |
| Net income | $3.3B | 19.61% | $968M | 10.24% | PFE +9.4pp |
| Stage | PFE | CMI | Gap · A − B |
|---|---|---|---|
| Revenue | $16.6B100.00% | $9.5B100.00% | PFE ×1.75 |
| Gross profit | 75.71%$12.6B | 26.07%$2.5B | PFE +49.6pp |
| Operating income | 22.14%$3.7B | 13.52%$1.3B | PFE +8.6pp |
| Pre-tax income | 20.41%$3.4B | 13.67%$1.3B | PFE +6.7pp |
| Net income |
| 19.61%$3.3B |
| 10.24%$968M |
| PFE +9.4pp |
No shared counterparties.